Cost-effectiveness of leucoreduction for prevention of febrile non-haemolytic transfusion reactions

BACKGROUND: The cost-effectiveness of universal leucoreduction of blood components remains unclear. When using leucoreduced red blood cells, the decrease in the rate of febrile non-haemolytic transfusion reactions (FNHTR) is the only proven, meaningful clinical benefit, whose relationship to costs c...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tsantes, Argirios E., Kyriakou, Elias, Nikolopoulos, Georgios K., Stylos, Dimitrios, Sidhom, Marlene, Bonovas, Stefanos, Douramani, Panagiota, Kalantzis, Dimitrios, Kokoris, Styliani, Valsami, Serena, Stamoulis, Konstantinos, Politou, Marianna, Foudoulaki-Paparizos, Leontini
Médium: Artigo
Jazyk:Inglês
Vydáno: Edizioni SIMTI - SIMTI Servizi Srl 2014
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4039706/
https://ncbi.nlm.nih.gov/pubmed/24931843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2014.0263-13
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky